Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | |
|---|---|---|---|---|---|
| Sales | 241.36 | 204.67 | 182.04 | 153.05 | 172.75 |
| Operating profit | 41.98 | 37.30 | 26.76 | 22.71 | 23.82 |
| Interest | 0.27 | 0.23 | 0.26 | 0.66 | 0.85 |
| Gross profit | 43.03 | 53.00 | 59.12 | 26.35 | 38.68 |
| EPS (Rs) | 0.56 | 0.69 | 0.98 | 0.39 | 0.64 |
Quarterly
results in details
| Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | |
|---|---|---|---|---|---|
| Other income | 1.33 | 15.93 | 32.62 | 4.30 | 15.71 |
| Stock adjustment | -1.46 | -5.90 | 2.25 | -7.38 | 1.10 |
| Raw material | 117.16 | 102.83 | 82.80 | 85.36 | 82.88 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 20.47 | 18.23 | 16.93 | 15.42 | 13.80 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 63.22 | 52.21 | 53.32 | 36.94 | 51.16 |
| Provisions made | - | - | - | - | - |
| Depreciation | 8.43 | 8.50 | 4.72 | 3.51 | 4.18 |
| Taxation | 9.31 | 13.21 | 10.20 | 5.04 | 8.88 |
| Net profit / loss | 25.29 | 31.29 | 44.19 | 17.81 | 25.62 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 45.32 | 45.32 | 45.32 | 45.32 | 40.30 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 17.39 | 18.22 | 14.70 | 14.84 | 13.79 |
| GPM (%) | 17.73 | 24.02 | 27.54 | 16.75 | 20.53 |
| NPM (%) | 10.42 | 14.18 | 20.59 | 11.32 | 13.60 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis